🔎 Trials Near Me

Home › Germ Cell and Embryonal Cancer

Germ Cell and Embryonal Cancer clinical trials recruiting in the U.S.

21 studies for Germ Cell and Embryonal Cancer are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Molecular Epidemiology of Pediatric Germ Cell Tumors

RecruitingObservational study
All ages · All sexes · Updated Nov 13, 2026 · NCT05564026

Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy

Recruiting
Ages 18 and older · Men · Updated Nov 10, 2026 · NCT06828185

Germ Cell Tumor and Testicular Tumor DNA Registry

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT02099734

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

RecruitingPhase 1
Ages 15 and older · All sexes · Updated Oct 9, 2026 · NCT06276491

A Study of ZW251 in Participants With Advanced Solid Tumors

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07164313

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

RecruitingPhase 3
Ages 11 to 50 · All sexes · Updated Sep 1, 2026 · NCT02582697

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

RecruitingPhase 1
12 Months – 25 Years · All sexes · Updated Aug 3, 2026 · NCT04099797

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07628634

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

RecruitingPhase 1/2
Ages 4 to 39 · All sexes · Updated Jul 20, 2026 · NCT05278208

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

RecruitingPhase 1
Up to age 21 · All sexes · Updated May 19, 2026 · NCT04897321

Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT

RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT04804007

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

RecruitingPhase 1
Ages 1 to 30 · All sexes · Updated Apr 15, 2026 · NCT04308330

Maintenance Zanzalintinib With Etoposide After HDCT in GCT

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT06937866

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.